SUMMARY The sensitivities to cefuroxime and cephradine of potentially pathogenic bacteria isolated in two British general hospitals comprising 900 beds have been assessed. In a three-month period, 2537 strains were studied; 30 tkg cefuroxime discs were used with 2511 strains, and cephradine discs of the same strength were used with 2525 strains. The organisms were also examined routinely for sensitivity to other antibiotics. Overall, 91[7 % of the isolates were sensitive to cefuroxime and 85-8 % were inhibited by cephradine, the differences in percentage strain susceptibility to cefuroxime and cephradine being mainly a result of the greater activity of cefuroxime against the Gram-negative bacteria. The wide antibacterial effectiveness of cefuroxime should make it a useful antibiotic for the treatment of serious infections including those conditions in which the causative organism has not been identified.
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Cefuroxime is a new semisynthetic cephalosporin antibiotic (O'Callaghan et al., 1976) which has marked stability to staphylococcal penicillinase and to a wide range of /3-lactamases produced by Gramnegative bacteria. The antibiotic penetrates the permeabilitybarrierprovidedbythe cell envelope of most Gram-negative bacteria, the major exception being Pseudomonas aeruginosa, which is impermeable to many antibiotics. Cefuroxime is also active against the penicillin-binding proteins of Gram-negative bacteria, with highest affinity for penicillin-binding protein 3 (Spratt, 1975) which is involved in cell division (N. A. C. Curtis, unpublished data). The contribution that cefuroxime can make in treating infectionsisdependent upon such factors as its /3-lactamase stability, cell penetrability, the incidence of infection with particular bacteria, and the comparison with current antibiotics. The aim of this study was to assess the usefulness of cefuroxime through analysis of sensitivity tests carried out on consecutive bacterial isolates from all specimens over a predetermined period.
Material and methods
For three months, from I May to 31 July 1977, a Received for publication 20 February 1979 prospective survey was conducted on all potentially pathogenic bacteria isolated from clinical specimens sent to the hospitals' bacteriology laboratory. No special precautions were taken to exclude identical bacteria from different or the same sources. Clinicians were not encouraged to submit more frequent specimens than was their normal practice. The source of the specimen was recorded (Table 1 ) and whether they originated from in-or out-patients. Gram-positive cocci were denoted as anaerobic streptococci whereas those requiring only reduced oxygen tension were referred to as microaerophilic streptococci. Clostridia were identified using the methods recommended by Cowan and Steel (1965) and neisseria were screened utilising the serum-free medium of Flynn and Waitkins (1972 Figure. The largest single group of organisms was E. coli (765 isolates, of which two gave atypical reactions), representing 30-2 % of the total bacterial ecology. The next most frequent isolate was Staph. aureus (359 strains), accounting for 14-2 % of the total population. Other major groups included Klebsiella spp (7-6 %) and Proteus spp (9-6 %). Bacteroides and pseudomonas were isolated with relative infrequency, being 2 0% and 1-7% respectively of the population; they generally came from wound swabs but pseudomonas also originated from urine specimens.
Figure Distribution of 2537 isolates over a three-month periodfrom two British general hospitals. The percentages represent the incidence of the various bacteria.
SENSITIVITI ES
Of the 2511 isolates examined, 2302 (91-7%) were sensitive to cefuroxime, and of the 2525 tested with cephradine, 2167 (85 8%) were sensitive. The sensitivities to cefuroxime of organisms from each type of clinical specimen are given in Table 1 . There were no appreciable differences between those bacteria isolated from inpatients and those from outpatients. Although cefuroxime was more consistently active than cephradine against both Gram-positive and L. 0. Potaschmacher, C. H. Dash, K. A. Jefferson, and Margaret R. K. Kennedy
Gram-negative bacteria, the difference was more marked for the Gram-negative strains, 90-2% of which were sensitive to cefuroxime compared with only 82-7% for cephradine. Cefuroxime was active against 93 8 % of the Gram-positive strains, cephradine against 90 3 %. In the whole survey there were only 18 strains sensitive to cephradine and resistant to cefuroxime but about nine times as many (168) resistant to cephradine but sensitive to cefuroxime. Most of these latter strains were Enterobacteriaceae. It was thought that the strains accidentally omitted from the sensitivity testing would not significantly have altered the overall results; only 11 organisms were not examined with either cephalosporin and, of those tested with only one cephalosporin, all were sensitive. Cefuroxime and cephradine were more comprehensively tested than the other antibiotics, the activity of which can therefore be compared with the cephalosporins only within specific groups of bacteria.
The results obtained for the staphylococci are shown in Table 2 . All but occasional strains of Staph. aureus were sensitive to the cephalosporins, methicillin, and erythromycin, but four-fifths of isolates were resistant to benzylpenicillin, including those from outpatients. Staph. epidermidis strains were cephalosporin sensitive with few exceptions, but methicillin, fusidic acid, and erythromycin were active against less than 90% of isolates.
Streptococcus pneumoniae strains were fully sensitive to the cephalosporins and to many other antibiotics (Table 3 ). All Streptococcus mitis (viridans group) strains were cefuroxime sensitive but not all strains were susceptible to the other antibiotics. All but one of the strains tested of streptococci of Lancefield's groups A, B, C, F, and G were sensitive to the first and second generation cephalosporins and benzylpenicillin; the exception, in group F, was sensitive to ampicillin. All 62 group B P-haemolytic streptococci, which were included in this group, were cephalosporin and penicillin sensitive.
There were 171 isolates of Streptococcus faecalis and two of Lancefield's group D, the total forming the fourth largest group of the survey. Cefuroxime was active against two-thirds of the strains, cephradine against half. The remaining 47 miscellaneous streptococci consisted of non-haemolytic aerobes (4), microaerophilic strains (17), and those not typing as groups A-D, F, or G (26). At least 95 % were sensitive to the majority of antibiotics (Table 3) . One strain of corynebacterium was tested in the survey; it was isolated in heavy growth from an eye swab. Table 5 demonstrates the results for the anaerobes. Metronidazole was tested against 43 of the 50 bacteroides isolates and was active against all of them. These included strains which were not further typed and which could therefore have been Bact. fragilis. Nonetheless, cefuroxime fared better against the bacteroides of unknown species than against the Bact. fragilis strains. Clindaymcin was tested against only 24 strains of bacteroides but was fully active. The only other antibiotic with any significant success against bacteroides was erythromycin but several antibiotics enjoyed reasonable activity against the clostridium isolates and the anaerobic streptococci (Table 4) .
Discussion
Cefuroxime was active against the vast majority of (Eykyn et al., 1976; Norrby et al., 1976; Jones et al., 1977) and the proportion of species producing this type of class I enzyme is probably the single most important factor responsible for the variabilities.
Cefuroxime has been shown to penetrate rapidly into the cell walls of most Gram-negative bacteria, and this is a contributory feature of its antibiotic effectiveness, but Ps. aeruginosa is relatively impermeable to many antibiotics, including cefuroxime. Despite the stability that cefuroxime has in the presence of the various f-lactamases that this organism can produce, notably the inducible, chromosomally mediated cephalosporinase described by Sabath and colleagues (1965) and the class III TEM-type enzymes, the species is not susceptible. The inactivity of cefuroxime against one-third of Strep. faecalis strains may be due partly to poor penetration of the antibiotic into the cell wall.
Bacteria from a wide variety of clinical specimens were generally found to be sensitive to cefuroxime (Table 1) . However, as other antibiotics were not universally tested in our study, partly because of presumed inactivity, overall comparisons cannot readily be made. Nonetheless it appears that cefuroxime exhibits wider antibacterial activity against current clinical isolates than any other antibiotic in our test schedule. Activity against two-thirds of Strep.faecalis strains and many isolates of Bacteroides spp make significant and clinically important contributions to the wide antibacterial cover afforded by cefuroxime.
This broad-spectrum activity should make it useful for the treatment of infections requiring prompt parenteral therapy when the causative pathogen has not been identified and is not thought likely to be Ps. aeruginosa. In our survey only one of 25 isolates from blood culture was resistant to cefuroxime. Encouraging therapeutic results in septicaemia have been reported by several authors (Gobemado et al., 1977; Shah et al., 1977; Geddes et al., 1978) .
The excellent in vitro activity of cefuroxime against Staph. epidermidis and Strep. mitis suggests that it may be useful in infections by those bacteria and especially in cases ofendocarditis. The low toxicity of cefuroxime would be an additional benefit in these circumstances. All of the Lancefield's group B ,Bhaemolytic streptococci were sensitive to cefuroxime, which promises that it may find a place in perinatal medicine although the fulminating course ofneonatal infections by group B streptococci is a disadvantage for all antibiotics.
Therapeutic concentrations of cefuroxime occur in the cerebrospinal fluid in meningitis (Kuzemko and Walker, 1977; Norrby et al., 1977; Renlund and Pettay, 1977; Wilkinson et al., 1977) . Excellent activity against Strep. pneumoniae, Neisseria meningitidis (Fallon and Brown, 1979) , H. influenzae, and E. coli make it an appropriate choice for meningitis in any age group.
In many acute chest infections the pathogen is not isolated. However, cefuroxime has good activity against the most likely bacteria, for example, H. influenzae and Strep. pneumoniae; in our survey it was active against 97.6 % of 126 isolates from sputum and has been found to be effective clinically (Miki, 1977; Pines et al., 1977; Seed et al., 1977; Bax et al., 1979) . Klebsiella spp, although resistant to many antibiotics, are frequently sensitive to cefuroxime. It has been shown to be successful clinically in epidemics caused by such strains (Bint et al., 1979) .
Cefuroxime shows great potential for a variety of infections in different sites, and initial clinical studies (Copland, 1977; Daikos et al., 1977; Graninger et al., 1977; Scott, 1977; Geddes et al., 1978) have so far borne out this promise.
